Senator Investment Group’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-400,000
Closed -$6.95M 75
2024
Q2
$6.95M Sell
400,000
-400,000
-50% -$7.09M 0.34% 50
2024
Q1
$15.7M Sell
800,000
-200,000
-20% -$4.22M 0.71% 44
2023
Q4
$23M Sell
1,000,000
-10,000
-1% -$224K 0.99% 38
2023
Q3
$23.2M Buy
1,010,000
+235,000
+30% +$5.98M 1.3% 28
2023
Q2
$20.2M Buy
775,000
+25,000
+3% +$660K 0.91% 36
2023
Q1
$20.7M Sell
750,000
-250,000
-25% -$6.6M 1.13% 29
2022
Q4
$22.7M Buy
1,000,000
+400,000
+67% +$11.1M 2.04% 14
2022
Q3
$20.4M Sell
600,000
-900,000
-60% -$33.3M 1.86% 23
2022
Q2
$43.7M Hold
1,500,000
3.13% 13
2022
Q1
$40.1M Sell
1,500,000
-100,000
-6% -$2.36M 1.24% 27
2021
Q4
$41.4M Buy
1,600,000
+700,000
+78% +$17.4M 0.8% 41
2021
Q3
$21.2M Buy
900,000
+250,000
+38% +$8.73M 0.36% 63
2021
Q2
$28.8M Buy
+650,000
New +$24M 0.55% 54

Other funds holding PRVA

Senator Investment Group's PRVA Position: Q3 2024 in Review

Senator Investment Group sold out of Privia Health (PRVA) in Q3 2024, closing a stake of 400,000 shares — an estimated $6.95M sold.

Senator Investment Group first reported a position in PRVA in Q2 2021 and held it in 13 quarters. The position peaked at $43.7M in Q2 2022. 234 funds tracked by Wall St. Rank hold PRVA as of Q3 2024.

  • Senator Investment Group reported no remaining Privia Health position as of Q3 2024 after selling out during the quarter.
  • Senator Investment Group sold 400,000 Privia Health shares in Q3 2024, an estimated $6.95M.
  • Senator Investment Group first reported a position in Privia Health in Q2 2021 and held it in 13 quarters.
  • Senator Investment Group's Privia Health position peaked at $43.7M in Q2 2022.
  • 234 funds tracked by Wall St. Rank held Privia Health as of Q3 2024.

Based on Senator Investment Group's 13F filing for Q3 2024, filed 13 Nov 2024.